nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—ITPR1—breast cancer	0.0108	0.0372	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—CFL1—breast cancer	0.00973	0.0336	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—FCGR activation—SRC—breast cancer	0.00775	0.0267	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—RNF182—breast cancer	0.00774	0.0267	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—CFL1—breast cancer	0.00735	0.0253	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—PAK1—breast cancer	0.00675	0.0233	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—HSP90AA1—breast cancer	0.00639	0.022	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CB—breast cancer	0.00573	0.0198	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—ABL1—breast cancer	0.00554	0.0191	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PIN1—breast cancer	0.00538	0.0186	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PAK1—breast cancer	0.00509	0.0176	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CUL5—breast cancer	0.00498	0.0172	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—HSP90AA1—breast cancer	0.00482	0.0166	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MX1—breast cancer	0.00447	0.0154	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—ITPR1—breast cancer	0.00421	0.0145	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—ABL1—breast cancer	0.00418	0.0144	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RNF182—breast cancer	0.00383	0.0132	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PRLR—breast cancer	0.0036	0.0124	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIN1—breast cancer	0.0036	0.0124	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CA—breast cancer	0.00349	0.012	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—UBE2C—breast cancer	0.00341	0.0118	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EVL—breast cancer	0.00306	0.0106	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MX1—breast cancer	0.00299	0.0103	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNB1—breast cancer	0.00283	0.00975	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD74—breast cancer	0.00277	0.00954	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TANK—breast cancer	0.00266	0.00917	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—TAB2—breast cancer	0.00265	0.00915	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—EGR1—breast cancer	0.00265	0.00912	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IFNG—breast cancer	0.00263	0.00907	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CUL5—breast cancer	0.00247	0.00851	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RNF182—breast cancer	0.00232	0.00801	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CB—breast cancer	0.00224	0.00772	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—MAPK3—breast cancer	0.00219	0.00755	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SQSTM1—breast cancer	0.00203	0.00699	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIN1—breast cancer	0.00202	0.00695	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—STIM1—breast cancer	0.00201	0.00693	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNB1—breast cancer	0.00189	0.00651	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EVL—breast cancer	0.00186	0.0064	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—SRC—breast cancer	0.00179	0.00618	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MRE11A—breast cancer	0.00178	0.00614	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—EGR1—breast cancer	0.00177	0.00609	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PRL—breast cancer	0.00174	0.006	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RPS6KB2—breast cancer	0.00169	0.00584	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—UBE2C—breast cancer	0.00169	0.00582	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD74—breast cancer	0.00168	0.00579	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK3—breast cancer	0.00165	0.0057	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RPS6KB2—breast cancer	0.00163	0.00561	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT5A—breast cancer	0.00155	0.00535	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TANK—breast cancer	0.00155	0.00534	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAP2K7—breast cancer	0.00153	0.00527	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CFL1—breast cancer	0.00153	0.00527	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD34—breast cancer	0.00152	0.00526	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CUL5—breast cancer	0.0015	0.00516	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TAB2—breast cancer	0.00149	0.00513	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAP3K1—breast cancer	0.00148	0.00509	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HGF—breast cancer	0.00146	0.00503	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CSF2—breast cancer	0.00144	0.00497	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TAB2—breast cancer	0.00143	0.00493	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—breast cancer	0.00136	0.0047	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—breast cancer	0.00128	0.00443	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STIM1—breast cancer	0.00122	0.00421	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Tamoxifen—breast cancer	0.00118	0.00166	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRLR—breast cancer	0.00117	0.00405	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIN1—breast cancer	0.00117	0.00405	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Chlorambucil—breast cancer	0.00117	0.00165	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSD—breast cancer	0.00117	0.00402	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Vinorelbine—breast cancer	0.00115	0.00163	CcSEcCtD
Methyl aminolevulinate—Pain—Vinblastine—breast cancer	0.00115	0.00162	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Epirubicin—breast cancer	0.00115	0.00162	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Melphalan—breast cancer	0.00115	0.00162	CcSEcCtD
Methyl aminolevulinate—Rash—Raloxifene—breast cancer	0.00114	0.00161	CcSEcCtD
Methyl aminolevulinate—Rash—Idarubicin—breast cancer	0.00114	0.00161	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Idarubicin—breast cancer	0.00114	0.00161	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Raloxifene—breast cancer	0.00114	0.00161	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF3—breast cancer	0.00114	0.00392	CbGpPWpGaD
Methyl aminolevulinate—Headache—Raloxifene—breast cancer	0.00114	0.0016	CcSEcCtD
Methyl aminolevulinate—Headache—Idarubicin—breast cancer	0.00114	0.0016	CcSEcCtD
Methyl aminolevulinate—Nausea—Anastrozole—breast cancer	0.00114	0.0016	CcSEcCtD
Methyl aminolevulinate—Nausea—Letrozole—breast cancer	0.00114	0.0016	CcSEcCtD
Methyl aminolevulinate—Erythema—Mitoxantrone—breast cancer	0.00113	0.00159	CcSEcCtD
Methyl aminolevulinate—Fatigue—Tamoxifen—breast cancer	0.00113	0.00159	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Goserelin—breast cancer	0.00112	0.00158	CcSEcCtD
Methyl aminolevulinate—Pain—Tamoxifen—breast cancer	0.00112	0.00158	CcSEcCtD
Methyl aminolevulinate—Infection—Vinorelbine—breast cancer	0.00111	0.00157	CcSEcCtD
Methyl aminolevulinate—Fatigue—Melphalan—breast cancer	0.0011	0.00156	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Doxorubicin—breast cancer	0.0011	0.00155	CcSEcCtD
Methyl aminolevulinate—Erythema—Gemcitabine—breast cancer	0.0011	0.00155	CcSEcCtD
Methyl aminolevulinate—Pain—Melphalan—breast cancer	0.0011	0.00154	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF3—breast cancer	0.00109	0.00377	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Fluorouracil—breast cancer	0.00108	0.00153	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Chlorambucil—breast cancer	0.00108	0.00153	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF4—breast cancer	0.00108	0.00373	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Raloxifene—breast cancer	0.00108	0.00152	CcSEcCtD
Methyl aminolevulinate—Nausea—Idarubicin—breast cancer	0.00108	0.00152	CcSEcCtD
Methyl aminolevulinate—Fatigue—Goserelin—breast cancer	0.00108	0.00152	CcSEcCtD
Methyl aminolevulinate—Pain—Goserelin—breast cancer	0.00107	0.00151	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Doxorubicin—breast cancer	0.00107	0.0015	CcSEcCtD
Methyl aminolevulinate—Infection—Thiotepa—breast cancer	0.00106	0.0015	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IFNB1—breast cancer	0.00106	0.00365	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PAK1—breast cancer	0.00106	0.00365	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Chlorambucil—breast cancer	0.00105	0.00149	CcSEcCtD
Methyl aminolevulinate—Pruritus—Chlorambucil—breast cancer	0.00104	0.00147	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF4—breast cancer	0.00104	0.00359	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Tamoxifen—breast cancer	0.00104	0.00146	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MRE11A—breast cancer	0.00104	0.00358	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40—breast cancer	0.00102	0.00353	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—UBE2C—breast cancer	0.00102	0.00353	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Melphalan—breast cancer	0.00102	0.00143	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PAK1—breast cancer	0.00102	0.00351	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTLA4—breast cancer	0.00101	0.00348	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Vinorelbine—breast cancer	0.00101	0.00142	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HSP90AA1—breast cancer	0.001	0.00346	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Goserelin—breast cancer	0.000993	0.0014	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Vinblastine—breast cancer	0.000993	0.0014	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Capecitabine—breast cancer	0.000992	0.0014	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Paclitaxel—breast cancer	0.000991	0.0014	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—RPS6KB2—breast cancer	0.000987	0.0034	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MX1—breast cancer	0.000975	0.00336	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Epirubicin—breast cancer	0.000975	0.00137	CcSEcCtD
Methyl aminolevulinate—Eye pain—Epirubicin—breast cancer	0.00097	0.00137	CcSEcCtD
Methyl aminolevulinate—Asthenia—Vinblastine—breast cancer	0.000967	0.00136	CcSEcCtD
Methyl aminolevulinate—Fatigue—Vinorelbine—breast cancer	0.000965	0.00136	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Tamoxifen—breast cancer	0.000964	0.00136	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Thiotepa—breast cancer	0.00096	0.00135	CcSEcCtD
Methyl aminolevulinate—Pain—Vinorelbine—breast cancer	0.000957	0.00135	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CD—breast cancer	0.000952	0.00328	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Mitoxantrone—breast cancer	0.000952	0.00134	CcSEcCtD
Methyl aminolevulinate—Discomfort—Irinotecan—breast cancer	0.000952	0.00134	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Melphalan—breast cancer	0.000944	0.00133	CcSEcCtD
Methyl aminolevulinate—Asthenia—Tamoxifen—breast cancer	0.000939	0.00132	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF10—breast cancer	0.000935	0.00323	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Gemcitabine—breast cancer	0.000927	0.00131	CcSEcCtD
Methyl aminolevulinate—Pruritus—Tamoxifen—breast cancer	0.000926	0.0013	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD34—breast cancer	0.000924	0.00319	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Mitoxantrone—breast cancer	0.000923	0.0013	CcSEcCtD
Methyl aminolevulinate—Oedema—Irinotecan—breast cancer	0.000923	0.0013	CcSEcCtD
Methyl aminolevulinate—Erythema—Paclitaxel—breast cancer	0.000923	0.0013	CcSEcCtD
Methyl aminolevulinate—Fatigue—Thiotepa—breast cancer	0.000922	0.0013	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Goserelin—breast cancer	0.000921	0.0013	CcSEcCtD
Methyl aminolevulinate—Asthenia—Melphalan—breast cancer	0.000919	0.0013	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MAPK3—breast cancer	0.000917	0.00316	CbGpPWpGaD
Methyl aminolevulinate—Infection—Mitoxantrone—breast cancer	0.000917	0.00129	CcSEcCtD
Methyl aminolevulinate—Infection—Irinotecan—breast cancer	0.000917	0.00129	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Epirubicin—breast cancer	0.000917	0.00129	CcSEcCtD
Methyl aminolevulinate—Pain—Thiotepa—breast cancer	0.000914	0.00129	CcSEcCtD
Methyl aminolevulinate—Discomfort—Fluorouracil—breast cancer	0.000911	0.00128	CcSEcCtD
Methyl aminolevulinate—Pruritus—Melphalan—breast cancer	0.000907	0.00128	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFA—breast cancer	0.000903	0.00311	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Doxorubicin—breast cancer	0.000902	0.00127	CcSEcCtD
Methyl aminolevulinate—Oedema—Gemcitabine—breast cancer	0.000899	0.00127	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF10—breast cancer	0.000898	0.0031	CbGpPWpGaD
Methyl aminolevulinate—Eye pain—Doxorubicin—breast cancer	0.000898	0.00126	CcSEcCtD
Methyl aminolevulinate—Asthenia—Goserelin—breast cancer	0.000897	0.00126	CcSEcCtD
Methyl aminolevulinate—Infection—Gemcitabine—breast cancer	0.000894	0.00126	CcSEcCtD
Methyl aminolevulinate—Dizziness—Vinblastine—breast cancer	0.000891	0.00125	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAP2K7—breast cancer	0.00089	0.00307	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CFL1—breast cancer	0.00089	0.00307	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Vinorelbine—breast cancer	0.000889	0.00125	CcSEcCtD
Methyl aminolevulinate—Pruritus—Goserelin—breast cancer	0.000884	0.00125	CcSEcCtD
Methyl aminolevulinate—Oedema—Fluorouracil—breast cancer	0.000884	0.00125	CcSEcCtD
Methyl aminolevulinate—Infection—Fluorouracil—breast cancer	0.000879	0.00124	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ITPR1—breast cancer	0.000876	0.00302	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Chlorambucil—breast cancer	0.000873	0.00123	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ERBB4—breast cancer	0.00087	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ABL1—breast cancer	0.00087	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFA—breast cancer	0.000867	0.00299	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TAB2—breast cancer	0.000867	0.00299	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Tamoxifen—breast cancer	0.000865	0.00122	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAP3K1—breast cancer	0.000859	0.00296	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—breast cancer	0.000857	0.00296	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—RAF1—breast cancer	0.00085	0.00293	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Thiotepa—breast cancer	0.000849	0.0012	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Doxorubicin—breast cancer	0.000848	0.00119	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—RELA—breast cancer	0.000846	0.00292	CbGpPWpGaD
Methyl aminolevulinate—Face oedema—Epirubicin—breast cancer	0.000846	0.00119	CcSEcCtD
Methyl aminolevulinate—Headache—Vinblastine—breast cancer	0.000844	0.00119	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ITPR1—breast cancer	0.000841	0.0029	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Docetaxel—breast cancer	0.00084	0.00118	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ERBB4—breast cancer	0.000835	0.00288	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CB—breast cancer	0.00083	0.00286	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Irinotecan—breast cancer	0.000829	0.00117	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Mitoxantrone—breast cancer	0.000829	0.00117	CcSEcCtD
Methyl aminolevulinate—Dizziness—Goserelin—breast cancer	0.000827	0.00116	CcSEcCtD
Methyl aminolevulinate—Rash—Tamoxifen—breast cancer	0.000825	0.00116	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Vinorelbine—breast cancer	0.000825	0.00116	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Tamoxifen—breast cancer	0.000824	0.00116	CcSEcCtD
Methyl aminolevulinate—Headache—Tamoxifen—breast cancer	0.00082	0.00115	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Capecitabine—breast cancer	0.000813	0.00114	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF1—breast cancer	0.000809	0.00279	CbGpPWpGaD
Methyl aminolevulinate—Rash—Melphalan—breast cancer	0.000808	0.00114	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Gemcitabine—breast cancer	0.000808	0.00114	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Melphalan—breast cancer	0.000807	0.00114	CcSEcCtD
Methyl aminolevulinate—Asthenia—Vinorelbine—breast cancer	0.000803	0.00113	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NRG1—breast cancer	0.000803	0.00277	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Vinblastine—breast cancer	0.0008	0.00113	CcSEcCtD
Methyl aminolevulinate—Fatigue—Irinotecan—breast cancer	0.000796	0.00112	CcSEcCtD
Methyl aminolevulinate—Fatigue—Mitoxantrone—breast cancer	0.000796	0.00112	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Fluorouracil—breast cancer	0.000794	0.00112	CcSEcCtD
Methyl aminolevulinate—Pruritus—Vinorelbine—breast cancer	0.000792	0.00112	CcSEcCtD
Methyl aminolevulinate—Pain—Irinotecan—breast cancer	0.00079	0.00111	CcSEcCtD
Methyl aminolevulinate—Pain—Mitoxantrone—breast cancer	0.00079	0.00111	CcSEcCtD
Methyl aminolevulinate—Rash—Goserelin—breast cancer	0.000788	0.00111	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Thiotepa—breast cancer	0.000788	0.00111	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Goserelin—breast cancer	0.000787	0.00111	CcSEcCtD
Methyl aminolevulinate—Headache—Goserelin—breast cancer	0.000783	0.0011	CcSEcCtD
Methyl aminolevulinate—Face oedema—Doxorubicin—breast cancer	0.000782	0.0011	CcSEcCtD
Methyl aminolevulinate—Erythema—Docetaxel—breast cancer	0.000782	0.0011	CcSEcCtD
Methyl aminolevulinate—Nausea—Tamoxifen—breast cancer	0.000777	0.00109	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD8A—breast cancer	0.000776	0.00268	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF1—breast cancer	0.000776	0.00268	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Paclitaxel—breast cancer	0.000776	0.00109	CcSEcCtD
Methyl aminolevulinate—Fatigue—Gemcitabine—breast cancer	0.000775	0.00109	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NRG1—breast cancer	0.000771	0.00266	CbGpPWpGaD
Methyl aminolevulinate—Pain—Gemcitabine—breast cancer	0.000769	0.00108	CcSEcCtD
Methyl aminolevulinate—Asthenia—Thiotepa—breast cancer	0.000767	0.00108	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—breast cancer	0.000765	0.00264	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2—breast cancer	0.000762	0.00263	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Melphalan—breast cancer	0.000761	0.00107	CcSEcCtD
Methyl aminolevulinate—Erythema—Capecitabine—breast cancer	0.000757	0.00107	CcSEcCtD
Methyl aminolevulinate—Pruritus—Thiotepa—breast cancer	0.000756	0.00107	CcSEcCtD
Methyl aminolevulinate—Pain—Fluorouracil—breast cancer	0.000756	0.00107	CcSEcCtD
Methyl aminolevulinate—Oedema—Paclitaxel—breast cancer	0.000753	0.00106	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ERBB3—breast cancer	0.000752	0.00259	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGFR2—breast cancer	0.000751	0.00259	CbGpPWpGaD
Methyl aminolevulinate—Infection—Paclitaxel—breast cancer	0.000748	0.00105	CcSEcCtD
Methyl aminolevulinate—Nausea—Goserelin—breast cancer	0.000743	0.00105	CcSEcCtD
Methyl aminolevulinate—Dizziness—Vinorelbine—breast cancer	0.00074	0.00104	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Methotrexate—breast cancer	0.000738	0.00104	CcSEcCtD
Methyl aminolevulinate—Urticaria—Mitoxantrone—breast cancer	0.000734	0.00103	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ERBB3—breast cancer	0.000722	0.00249	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGFR2—breast cancer	0.000721	0.00249	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSD—breast cancer	0.000708	0.00244	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Thiotepa—breast cancer	0.000707	0.000996	CcSEcCtD
Methyl aminolevulinate—Rash—Vinorelbine—breast cancer	0.000706	0.000994	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Vinorelbine—breast cancer	0.000705	0.000993	CcSEcCtD
Methyl aminolevulinate—Urticaria—Fluorouracil—breast cancer	0.000703	0.00099	CcSEcCtD
Methyl aminolevulinate—Headache—Vinorelbine—breast cancer	0.000701	0.000988	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGFR1—breast cancer	0.0007	0.00241	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2L1—breast cancer	0.000692	0.00239	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Epirubicin—breast cancer	0.000691	0.000973	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Irinotecan—breast cancer	0.00068	0.000958	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Mitoxantrone—breast cancer	0.00068	0.000958	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Paclitaxel—breast cancer	0.000676	0.000952	CcSEcCtD
Methyl aminolevulinate—Rash—Thiotepa—breast cancer	0.000674	0.00095	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Thiotepa—breast cancer	0.000674	0.000949	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGFR1—breast cancer	0.000672	0.00232	CbGpPWpGaD
Methyl aminolevulinate—Headache—Thiotepa—breast cancer	0.00067	0.000943	CcSEcCtD
Methyl aminolevulinate—Nausea—Vinorelbine—breast cancer	0.000665	0.000937	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGF3—breast cancer	0.000663	0.00228	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SQSTM1—breast cancer	0.000663	0.00228	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Irinotecan—breast cancer	0.000663	0.000933	CcSEcCtD
Methyl aminolevulinate—Asthenia—Mitoxantrone—breast cancer	0.000663	0.000933	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Fluorouracil—breast cancer	0.000652	0.000918	CcSEcCtD
Methyl aminolevulinate—Fatigue—Paclitaxel—breast cancer	0.000649	0.000914	CcSEcCtD
Methyl aminolevulinate—Asthenia—Gemcitabine—breast cancer	0.000645	0.000909	CcSEcCtD
Methyl aminolevulinate—Pain—Paclitaxel—breast cancer	0.000644	0.000907	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—breast cancer	0.000641	0.00221	CbGpPWpGaD
Methyl aminolevulinate—Photosensitivity reaction—Doxorubicin—breast cancer	0.000639	0.000901	CcSEcCtD
Methyl aminolevulinate—Oedema—Docetaxel—breast cancer	0.000638	0.000899	CcSEcCtD
Methyl aminolevulinate—Discomfort—Capecitabine—breast cancer	0.000637	0.000897	CcSEcCtD
Methyl aminolevulinate—Pruritus—Gemcitabine—breast cancer	0.000636	0.000896	CcSEcCtD
Methyl aminolevulinate—Nausea—Thiotepa—breast cancer	0.000635	0.000895	CcSEcCtD
Methyl aminolevulinate—Infection—Docetaxel—breast cancer	0.000634	0.000893	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGF4—breast cancer	0.000631	0.00218	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NFKBIA—breast cancer	0.000627	0.00216	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Fluorouracil—breast cancer	0.000626	0.000881	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD40—breast cancer	0.000621	0.00214	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Capecitabine—breast cancer	0.000618	0.00087	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PAK1—breast cancer	0.000617	0.00213	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNB1—breast cancer	0.000617	0.00213	CbGpPWpGaD
Methyl aminolevulinate—Infection—Capecitabine—breast cancer	0.000614	0.000865	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAPK3—breast cancer	0.000613	0.00211	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTLA4—breast cancer	0.000612	0.00211	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Irinotecan—breast cancer	0.000611	0.00086	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KIT—breast cancer	0.000607	0.00209	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Methotrexate—breast cancer	0.000605	0.000852	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NFKBIA—breast cancer	0.000602	0.00208	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EGF—breast cancer	0.0006	0.00207	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Paclitaxel—breast cancer	0.000598	0.000843	CcSEcCtD
Methyl aminolevulinate—Dizziness—Fluorouracil—breast cancer	0.000585	0.000824	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HSP90AA1—breast cancer	0.000584	0.00201	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KIT—breast cancer	0.000583	0.00201	CbGpPWpGaD
Methyl aminolevulinate—Rash—Mitoxantrone—breast cancer	0.000582	0.00082	CcSEcCtD
Methyl aminolevulinate—Rash—Irinotecan—breast cancer	0.000582	0.00082	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Irinotecan—breast cancer	0.000582	0.000819	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Mitoxantrone—breast cancer	0.000582	0.000819	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FOS—breast cancer	0.000579	0.002	CbGpPWpGaD
Methyl aminolevulinate—Headache—Mitoxantrone—breast cancer	0.000578	0.000815	CcSEcCtD
Methyl aminolevulinate—Headache—Irinotecan—breast cancer	0.000578	0.000815	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—EGR1—breast cancer	0.000577	0.00199	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EGF—breast cancer	0.000576	0.00199	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Docetaxel—breast cancer	0.000573	0.000807	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRL—breast cancer	0.000568	0.00196	CbGpPWpGaD
Methyl aminolevulinate—Rash—Gemcitabine—breast cancer	0.000567	0.000799	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Gemcitabine—breast cancer	0.000567	0.000798	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Epirubicin—breast cancer	0.000566	0.000798	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CASP8—breast cancer	0.000565	0.00195	CbGpPWpGaD
Methyl aminolevulinate—Erythema—Methotrexate—breast cancer	0.000564	0.000794	CcSEcCtD
Methyl aminolevulinate—Headache—Gemcitabine—breast cancer	0.000563	0.000794	CcSEcCtD
Methyl aminolevulinate—Rash—Fluorouracil—breast cancer	0.000558	0.000785	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Fluorouracil—breast cancer	0.000557	0.000785	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT2—breast cancer	0.000556	0.00192	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Capecitabine—breast cancer	0.000555	0.000782	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Paclitaxel—breast cancer	0.000555	0.000781	CcSEcCtD
Methyl aminolevulinate—Headache—Fluorouracil—breast cancer	0.000554	0.00078	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—KRAS—breast cancer	0.00055	0.0019	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Docetaxel—breast cancer	0.00055	0.000775	CcSEcCtD
Methyl aminolevulinate—Nausea—Irinotecan—breast cancer	0.000548	0.000773	CcSEcCtD
Methyl aminolevulinate—Nausea—Mitoxantrone—breast cancer	0.000548	0.000773	CcSEcCtD
Methyl aminolevulinate—Pain—Docetaxel—breast cancer	0.000546	0.000769	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGF10—breast cancer	0.000545	0.00188	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Paclitaxel—breast cancer	0.00054	0.000761	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDH1—breast cancer	0.000537	0.00185	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Gemcitabine—breast cancer	0.000534	0.000753	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CD—breast cancer	0.000534	0.00184	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT2—breast cancer	0.000533	0.00184	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Capecitabine—breast cancer	0.000533	0.00075	CcSEcCtD
Methyl aminolevulinate—Pruritus—Paclitaxel—breast cancer	0.000533	0.00075	CcSEcCtD
Methyl aminolevulinate—Pain—Capecitabine—breast cancer	0.000528	0.000744	CcSEcCtD
Methyl aminolevulinate—Erythema—Epirubicin—breast cancer	0.000528	0.000743	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFA—breast cancer	0.000526	0.00181	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Fluorouracil—breast cancer	0.000525	0.00074	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Doxorubicin—breast cancer	0.000524	0.000738	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CD—breast cancer	0.000513	0.00177	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ITPR1—breast cancer	0.00051	0.00176	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ERBB4—breast cancer	0.000507	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ABL1—breast cancer	0.000507	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT5A—breast cancer	0.000507	0.00175	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—breast cancer	0.000506	0.00174	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Paclitaxel—breast cancer	0.000498	0.000701	CcSEcCtD
Methyl aminolevulinate—Urticaria—Capecitabine—breast cancer	0.000491	0.000691	CcSEcCtD
Methyl aminolevulinate—Erythema—Doxorubicin—breast cancer	0.000488	0.000687	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2—breast cancer	0.000485	0.00167	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MDM2—breast cancer	0.000478	0.00165	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RAF1—breast cancer	0.000477	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HGF—breast cancer	0.000476	0.00164	CbGpPWpGaD
Methyl aminolevulinate—Rash—Paclitaxel—breast cancer	0.000475	0.000669	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RELA—breast cancer	0.000474	0.00164	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Paclitaxel—breast cancer	0.000474	0.000668	CcSEcCtD
Methyl aminolevulinate—Discomfort—Methotrexate—breast cancer	0.000474	0.000668	CcSEcCtD
Methyl aminolevulinate—Headache—Paclitaxel—breast cancer	0.000472	0.000664	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ERBB2—breast cancer	0.000471	0.00163	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD8A—breast cancer	0.000471	0.00162	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CSF2—breast cancer	0.000471	0.00162	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF1—breast cancer	0.000471	0.00162	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Docetaxel—breast cancer	0.00047	0.000662	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HRAS—breast cancer	0.000468	0.00161	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NRG1—breast cancer	0.000467	0.00161	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MTOR—breast cancer	0.000465	0.0016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CB—breast cancer	0.000465	0.0016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD4—breast cancer	0.000464	0.0016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MDM2—breast cancer	0.000459	0.00158	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Docetaxel—breast cancer	0.000458	0.000645	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RAF1—breast cancer	0.000458	0.00158	CbGpPWpGaD
Methyl aminolevulinate—Infection—Methotrexate—breast cancer	0.000457	0.000644	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RELA—breast cancer	0.000456	0.00157	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Capecitabine—breast cancer	0.000455	0.000641	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ERBB2—breast cancer	0.000453	0.00156	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Docetaxel—breast cancer	0.000452	0.000636	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—breast cancer	0.000448	0.00154	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Paclitaxel—breast cancer	0.000447	0.00063	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CB—breast cancer	0.000447	0.00154	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MTOR—breast cancer	0.000447	0.00154	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD4—breast cancer	0.000446	0.00154	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Epirubicin—breast cancer	0.000444	0.000625	CcSEcCtD
Methyl aminolevulinate—Asthenia—Capecitabine—breast cancer	0.000443	0.000625	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ERBB3—breast cancer	0.000438	0.00151	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGFR2—breast cancer	0.000437	0.00151	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Capecitabine—breast cancer	0.000437	0.000616	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1B—breast cancer	0.000437	0.00151	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Epirubicin—breast cancer	0.000431	0.000606	CcSEcCtD
Methyl aminolevulinate—Infection—Epirubicin—breast cancer	0.000428	0.000602	CcSEcCtD
Methyl aminolevulinate—Dizziness—Docetaxel—breast cancer	0.000422	0.000595	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1B—breast cancer	0.000419	0.00145	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JUN—breast cancer	0.000416	0.00143	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Methotrexate—breast cancer	0.000413	0.000582	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CTNNB1—breast cancer	0.000412	0.00142	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Doxorubicin—breast cancer	0.000411	0.000578	CcSEcCtD
Methyl aminolevulinate—Dizziness—Capecitabine—breast cancer	0.000409	0.000576	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FGFR1—breast cancer	0.000408	0.00141	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CDKN1A—breast cancer	0.000403	0.00139	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2L1—breast cancer	0.000403	0.00139	CbGpPWpGaD
Methyl aminolevulinate—Rash—Docetaxel—breast cancer	0.000402	0.000567	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Docetaxel—breast cancer	0.000402	0.000566	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTEN—breast cancer	0.000402	0.00139	CbGpPWpGaD
Methyl aminolevulinate—Headache—Docetaxel—breast cancer	0.0004	0.000563	CcSEcCtD
Methyl aminolevulinate—Oedema—Doxorubicin—breast cancer	0.000398	0.000561	CcSEcCtD
Methyl aminolevulinate—Fatigue—Methotrexate—breast cancer	0.000397	0.000559	CcSEcCtD
Methyl aminolevulinate—Infection—Doxorubicin—breast cancer	0.000396	0.000557	CcSEcCtD
Methyl aminolevulinate—Pain—Methotrexate—breast cancer	0.000393	0.000554	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK8—breast cancer	0.000393	0.00136	CbGpPWpGaD
Methyl aminolevulinate—Rash—Capecitabine—breast cancer	0.00039	0.000549	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Capecitabine—breast cancer	0.000389	0.000548	CcSEcCtD
Methyl aminolevulinate—Headache—Capecitabine—breast cancer	0.000387	0.000545	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CDKN1A—breast cancer	0.000387	0.00133	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Epirubicin—breast cancer	0.000387	0.000545	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTEN—breast cancer	0.000386	0.00133	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Docetaxel—breast cancer	0.000379	0.000534	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—SRC—breast cancer	0.000373	0.00129	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Epirubicin—breast cancer	0.000371	0.000523	CcSEcCtD
Methyl aminolevulinate—Pain—Epirubicin—breast cancer	0.000368	0.000519	CcSEcCtD
Methyl aminolevulinate—Nausea—Capecitabine—breast cancer	0.000367	0.000517	CcSEcCtD
Methyl aminolevulinate—Urticaria—Methotrexate—breast cancer	0.000365	0.000515	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—NFKBIA—breast cancer	0.000365	0.00126	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SRC—breast cancer	0.000358	0.00123	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Doxorubicin—breast cancer	0.000358	0.000504	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—KIT—breast cancer	0.000354	0.00122	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EGF—breast cancer	0.00035	0.00121	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK3—breast cancer	0.000343	0.00118	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Doxorubicin—breast cancer	0.000343	0.000484	CcSEcCtD
Methyl aminolevulinate—Urticaria—Epirubicin—breast cancer	0.000342	0.000482	CcSEcCtD
Methyl aminolevulinate—Pain—Doxorubicin—breast cancer	0.000341	0.00048	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Methotrexate—breast cancer	0.000339	0.000477	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—FOS—breast cancer	0.000337	0.00116	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Methotrexate—breast cancer	0.00033	0.000465	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CASP8—breast cancer	0.000329	0.00114	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EGFR—breast cancer	0.000327	0.00113	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Methotrexate—breast cancer	0.000325	0.000458	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDH1—breast cancer	0.000325	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT2—breast cancer	0.000324	0.00112	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Epirubicin—breast cancer	0.000317	0.000447	CcSEcCtD
Methyl aminolevulinate—Urticaria—Doxorubicin—breast cancer	0.000316	0.000446	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EGFR—breast cancer	0.000314	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CD—breast cancer	0.000311	0.00107	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Epirubicin—breast cancer	0.000309	0.000435	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KRAS—breast cancer	0.000309	0.00106	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Epirubicin—breast cancer	0.000305	0.000429	CcSEcCtD
Methyl aminolevulinate—Dizziness—Methotrexate—breast cancer	0.000304	0.000428	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KRAS—breast cancer	0.000296	0.00102	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Doxorubicin—breast cancer	0.000294	0.000413	CcSEcCtD
Methyl aminolevulinate—Rash—Methotrexate—breast cancer	0.00029	0.000409	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Methotrexate—breast cancer	0.00029	0.000408	CcSEcCtD
Methyl aminolevulinate—Headache—Methotrexate—breast cancer	0.000288	0.000406	CcSEcCtD
Methyl aminolevulinate—Asthenia—Doxorubicin—breast cancer	0.000286	0.000403	CcSEcCtD
Methyl aminolevulinate—Dizziness—Epirubicin—breast cancer	0.000285	0.000401	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—breast cancer	0.000284	0.000978	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2—breast cancer	0.000283	0.000975	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Doxorubicin—breast cancer	0.000282	0.000397	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—breast cancer	0.00028	0.000966	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MDM2—breast cancer	0.000279	0.00096	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RAF1—breast cancer	0.000278	0.000957	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RELA—breast cancer	0.000276	0.000953	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ERBB2—breast cancer	0.000275	0.000947	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Methotrexate—breast cancer	0.000273	0.000385	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—breast cancer	0.000272	0.000939	CbGpPWpGaD
Methyl aminolevulinate—Rash—Epirubicin—breast cancer	0.000271	0.000382	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Epirubicin—breast cancer	0.000271	0.000382	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MTOR—breast cancer	0.000271	0.000934	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CB—breast cancer	0.000271	0.000934	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD4—breast cancer	0.00027	0.000933	CbGpPWpGaD
Methyl aminolevulinate—Headache—Epirubicin—breast cancer	0.00027	0.00038	CcSEcCtD
Methyl aminolevulinate—Dizziness—Doxorubicin—breast cancer	0.000263	0.000371	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HRAS—breast cancer	0.000262	0.000905	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Epirubicin—breast cancer	0.000256	0.00036	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1B—breast cancer	0.000254	0.000877	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HRAS—breast cancer	0.000252	0.000869	CbGpPWpGaD
Methyl aminolevulinate—Rash—Doxorubicin—breast cancer	0.000251	0.000354	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—breast cancer	0.000251	0.000866	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Doxorubicin—breast cancer	0.000251	0.000353	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—breast cancer	0.00025	0.000861	CbGpPWpGaD
Methyl aminolevulinate—Headache—Doxorubicin—breast cancer	0.00025	0.000352	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IL2—breast cancer	0.000249	0.000858	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—JUN—breast cancer	0.000242	0.000835	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTNNB1—breast cancer	0.00024	0.000828	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Doxorubicin—breast cancer	0.000237	0.000333	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CDKN1A—breast cancer	0.000235	0.000809	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTEN—breast cancer	0.000234	0.000807	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT1—breast cancer	0.000232	0.000799	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK8—breast cancer	0.000229	0.00079	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT1—breast cancer	0.000222	0.000767	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SRC—breast cancer	0.000217	0.000749	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—breast cancer	0.000209	0.000722	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK3—breast cancer	0.0002	0.00069	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EGFR—breast cancer	0.00019	0.000656	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—KRAS—breast cancer	0.00018	0.00062	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—breast cancer	0.000165	0.00057	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HRAS—breast cancer	0.000153	0.000527	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—breast cancer	0.000146	0.000504	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT1—breast cancer	0.000135	0.000465	CbGpPWpGaD
